Navigation Links
Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
Date:8/14/2012

157300,571Net loss $  (1,875,447)$  (1,763,306)$(4,469,483)$ (3,451,946)Net loss per common  share – basic and diluted$
(0.02)$
(0.02)$
(0.04)$
(0.04)Weighted average common shares outstanding  – basic and diluted119,617,35683,097,967114,448,25483,097,967*Please refer to the reconciliation of Non-GAAP measures included in this release. 

 Selected Condensed Consolidated Balance Sheet DataJune 30, 

2012December 31,

2011Cash and cash equivalents$
,271,500$
4,721,279Restricted cash50,000200,000Accounts receivable9,757-Inventory771,867434,130Prepaid expenses and other current assets182,16068,204Property and equipment, net102,872135,581Other long-term assets1,876,8311,944,035Total assets$
9,264,987$
7,503,229Accounts payable and accrued liabilities$
,057,429$
,214,480Derivative liabilities-85,506Long-term liabilities87,026118,313Total liabilities1,144,4551,418,299Stockholder's equity 8,120,5326,084,930Total liabilities and stockholder's equity$
9,264,987$
7,503,299 

 Cardium Therapeutics, Inc.Reconciliation of Non-GAAP Measure As of June 30, 2012Three months ended June 30,Six months ended June 30,2012201120122011Net loss$
(1,875,447)$
(1,763,306)$ (4,469,483)$   (3,451,946)Add (subtract)Stock based compensation expense43,60659,00986,84581,529Change in fair value of derivative liabilities-(212,401)(64,157)(300,571)Non-GAAP net loss $
(1,831,841)$
(1,916,698)$ (4,446,795)$   (3,670,988)Non-GAAP net loss per common  share – basic and diluted$
(0.02)$
(0.02)$
(0.04)$
(0.04)Weighted average common shares outstanding  – basic and diluted119,617,35683,097,967114,448,25483,097,967Non-GAAP Financial MeasureTo supplement our condensed consolidated financial statements, which statements are prepared and presented in accordance with accounting principles generally accepted in the United States of America (GA
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
2. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
3. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
4. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
5. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
6. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
7. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
8. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
9. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
10. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
11. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE MKT: ... biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... the Company achieved the Public Notice (Gong Shi) ... of TPI,s Qionglai Facility (QLF) from the China ... period is a significant procedure of GMP certification ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
(Date:12/25/2014)... Among early stage breast cancer patients who undergo chemotherapy ... will eventually develop leukemia as a result of their ... from a review of more than 20,000 breast cancer ... that the risk for developing treatment-related leukemia, though low, ... "The frequency of bone marrow cancers such as leukemia ...
(Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
(Date:12/25/2014)... Parker & Sons, Inc. an industry leader ... quality regarding heating, cooling and plumbing services in the ... the “Queen of Clean” for impressive contractor services in ... over the years for providing outstanding quality customer service ... services for both homeowners and businesses. Linda Cobb, known ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Connie Casad, ... and functional medicine advocate with 30 years of practice ... to evaluate the health benefits of dietary detoxification. The ... new participants following excellent results from test patients who ... asked to explain her interest in conducting the study, ...
(Date:12/24/2014)... 2014 Dr. Vu Ho, a Dallas ... his practice and med-spa with the addition of new ... of cosmetic treatments and services. , “Silk Peel is ... says Dr. Ho. “As a result it can address ... sun spots, discolorations or blemishes.” , Similar to microdermabrasion, ...
Breaking Medicine News(10 mins):Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2
... that the strongest risk factors for atrial fibrillation in both ... While hypertension is a well known risk factor for AF, ... later occurrence of AF has not been documented earlier". ... and is a major risk factor for heart failure (risk ...
... administering a common chemotherapy drug before bone tumors took ... once introduced, to seed and grow more easily. ... some cancers metastasize to bone, and could eventually result ... the Department of Periodontics and Oral Medicine at the ...
... (HealthDay News) -- People with HIV/AIDS are four times more ... the general population, a new study finds. The findings ... researchers from the University of California, San Francisco (UCSF). In ... the heart suddenly and unexpectedly stops beating. The researchers ...
... that looked at the hunger trends over a 10-year period ... more than one in seven, face the threat of hunger. ... reported that one in nine seniors faced the threat of ... agricultural and consumer economics and executive director of the National ...
... team of international scientists has made a significant breakthrough in ... of liver cancer. By identifying several new genes frequently mutated ... better understanding of how bile duct cancers develop. Their discovery ... Duct Cancer, or Cholangiocarcinoma, is a fatal cancer with a ...
... University researcher Julia Frugoli has received $132,769 as the ... the National Science Foundation to continue her study of ... to control their growth and development. The work ... of Agriculture, Forestry & Life Sciences, genetics and biochemistry ...
Cached Medicine News:Health News:Palpitations are predictive of future atrial fibrillation 2Health News:Palpitations are predictive of future atrial fibrillation 3Health News:'Fertilizing' bone marrow helps answer why some cancers spread to bones 2Health News:People With HIV at Higher Odds of Sudden Cardiac Death 2Health News:Great recession reflux amounts to more hunger among seniors 2Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 2Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 3Health News:Clemson professor awarded nearly $600,000 4-year grant to study language of plants 2
... & Nephew offers a wide variety of ... available in both partially threaded and fully ... are the 5.5 and 7.0 mm products. ... the surgeon's job a little easier. Ratchet ...
... Nailing System is one of the first ... for either an antegrade or a retrograde ... , ,Stryker Orthopaedics Trauma has now created ... together all the capabilities and benefits of ...
... Humeral Nail System has been designed to ... noninvasive treatments have historically failed to give ... blend of strength and flexibility. Ideally suited ... titanium alloy is twice that of stainless ...
... nailing techniques have largely replaced the use of plates ... The use of rods or pins in the forearm ... has been no way to lock the pins or ... a non-locked nail is back out of the implant. ...
Medicine Products: